Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Mayo Clin Proc. 2020 Jun;95(6):1195–1205. doi: 10.1016/j.mayocp.2020.01.028

Table 1.

Characteristics of the Study Population by Age (N=1,462)

Age Decade, y
Characteristicb 50–59 (n=296) 60–69 (n=522) 70–79 (n=373) 80–89 (n=271)
Male sex 153 (51.7) 261 (50.0) 195 (52.3) 161 (59.4)
Age, median (range), y 55 (50–59) 65 (60–69) 75 (70–79) 83 (80–89)
Education, median (range), y 16 (9–20) 15 (6–20) 14 (6–20) 14 (7–20)
APOEa 83 (29.1) 149 (28.7) 115 (30.8) 69 (25.5)
Atrial fibrillation 5 (1.7) 26 (5.0) 36 (9.7) 60 (22.1)
Hypertension 93 (31.4) 280 (53.6) 247 (66.4) 222 (81.9)
Diabetes mellitus 30 (10.1) 75 (14.4) 69 (18.5) 61 (22.5)
Dyslipidemia 195 (65.9) 420 (80.5) 304 (81.7) 243 (89.7)
Coronary artery disease 20 (6.8) 88 (16.9) 104 (28.0) 123 (45.4)
Smoking status (ever) 111 (37.5) 242 (46.3) 188 (50.4) 115 (42.5)
a

APOE4=apolipoprotein Epsilon 4

b

Values are presented as number (percentage) of patients unless specified otherwise. Data were missing for APOE4 (n=14), atrial fibrillation (n=1), hypertension (n=1), diabetes mellitus (n=1), dyslipidemia (n=1), and coronary artery disease (n=1).